feed,title,long_url,short_url
Benzinga,H.C. Wainwright reiterates 'Buy' for Co-Diagnostics (NASDAQ:CODX) with a $35 Price Target as COVID-19 Surge Boosts Testing Demand,https://www.benzinga.com/pressreleases/20/07/g16613474/h-c-wainwright-reiterates-buy-for-co-diagnostics-nasdaq-codx-with-a-35-price-target-as-covid-19-su,https://j.mp/3066ylT
